Haleon (HLNCF) EPS (Basic) (2021 - 2023)

Haleon (HLNCF) recorded quarterly EPS (Basic) of $0.04 in Q4 2023, up 1120.45% on a QoQ basis from $0.0 in Q2 2023, and up 5.82% year-over-year from $0.04 in Q4 2022.

Haleon (HLNCF) EPS (Basic) (2021 - 2023) Analysis & Trends

Haleon has disclosed EPS (Basic) across 3 years of filings, most recently posting $0.04 for Q4 2023.

  • Quarterly EPS (Basic) rose 5.82% year-over-year to $0.04 in Q4 2023, while the trailing twelve-month figure through Dec 2025 was $0.04 (down 7.57% YoY) and the FY2025 annual result came in at $0.25, up 21.43% from the prior year.
  • EPS (Basic) climbed to $0.04 in Q4 2023, from $0.0 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.21 in Q3 2022 and troughed at $0.0 in Q2 2023.
  • A 3-year average of $0.08 and a median of $0.05 in 2023 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2022 — EPS (Basic) slumped 45.41% — and 2023, when it rose 5.82%.
  • Tracing HLNCF's EPS (Basic) over 3 years: stood at $0.07 in 2021, then sank by 45.41% to $0.04 in 2022, then grew by 5.82% to $0.04 in 2023.
  • Business Quant data shows HLNCF's EPS (Basic) at $0.04 in Q4 2023, $0.0 in Q2 2023, and $0.09 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.32
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 1.42
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.32
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.02
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.97
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.11
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -0.40
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -0.40
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.83
10 Haleon - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 0.04
Jun 30, 2023 0.00
May 3, 2023 0.09
Dec 31, 2022 0.04
Sep 20, 2022 0.21
Dec 31, 2021 0.07